Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice by Stevens Paula J, Demuth Jeffrey P, Thacker Robert I, Gropp Kathryn E, Dietrich Jefferey A, Reichart Deborah L, Dolan Elizabeth T, Lefever Frank R, Hinkle Richard T, Qu Xiaoyan A, Varbanov Alex R, Wang Feng, Isfort Robert J

Get full text